{"id":6391,"date":"2022-02-17T07:22:04","date_gmt":"2022-02-17T06:22:04","guid":{"rendered":"https:\/\/finascope.fr\/?p=6391"},"modified":"2022-02-18T13:14:45","modified_gmt":"2022-02-18T12:14:45","slug":"aelis-farma-a-reussi-son-introduction-en-bourse","status":"publish","type":"post","link":"https:\/\/finascope.fr\/english\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/","title":{"rendered":"Aelis Farma has successfully completed its IPO"},"content":{"rendered":"<p><span style=\"color: #1e73be;\"><span style=\"font-weight: 400;\">The biopharmaceutical company is raising approximately \u20ac25 million on Euronext Paris, at \u20ac14.02 per share, at the bottom of the indicative listing range. Trading begins tomorrow.\u00a0<\/span><\/span><\/p>\n<p><span style=\"font-weight: 400;\">After Haffner Energy, Aelis Farma has just completed a new IPO in Paris, the fifth listing of the year, according to Euronext. The Bordeaux-based biopharmaceutical company has succeeded in convincing investors of its plans to treat brain diseases.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">It is nevertheless a half-success since the subscription commitments reached 16.5 million euros, even before the beginning of the placement: 9.8 million euros from Indivior, one of the world leaders in the treatment of addictions, and 6.7 million euros from \"historical shareholders and a new investor\".<\/span><\/p>\n<h2>High market volatility<\/h2>\n<p><span style=\"font-weight: 400;\">If the amount of the transaction reaches \u20ac25 million, i.e. 100% of the initial target, the price of \u20ac14.02 per share is on the lower end of the indicative price range, announced at the time of the launch of the transaction, set between \u20ac14.02 and \u20ac16.82.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The issuer evokes a strong market volatility, while the marketing of the securities coincided with the tensions between Russia and Ukraine and the fears related to a faster and wider than expected increase in interest rates. The size of the transaction may however be increased to 25.55 million euros in case of full exercise of the over-allotment option.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Trading will start this Friday on the regulated market (compartment B) of Euronext Paris, whereas the issuer had chosen to enter the stock market through the large <a href=\"https:\/\/finascope.fr\/english\/operations\/aelis-farma-veut-entrer-en-bourse-par-la-grande-porte\/\" target=\"_blank\" rel=\"noopener\">door<\/a>. Most SMEs opt for the Growth compartment, because of the lighter constraints.<\/span><\/p>\n<h2>Capitalization: 175 million euros<\/h2>\n<p><span style=\"font-weight: 400;\">Based on a price per share of \u20ac14.02, the capitalization of Aelis Farma will amount to approximately \u20ac175 million after the capital increase.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\"<em>Aelis Farma is developing a new class of drugs: specific inhibitors of CB1 receptor signaling (CB1-SSi) of the endocannabinoid system that provide access to several therapeutic areas without available treatments. These unique drug candidates, by mimicking a recently discovered natural defense mechanism of the brain, appear capable of treating various brain pathologies without disrupting normal behavior. A first in pharmacology<\/em>\", explains <a href=\"https:\/\/www.aelisfarma.com\/\" target=\"_blank\" rel=\"noopener\">the sender<\/a>.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The first two are already in clinical trials, AEF0117 to treat cannabis abuse disorders and AEF0217 to treat various cognitive deficits, including those related to Down syndrome (Trisomy 21).<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\"<em>The capital increase will help select and bring to the clinic additional drug candidates from our innovative research platform for the treatment of some of the many brain diseases associated with dysregulation of CB1 receptor activity<\/em>\"said Pier Vincenzo Piazza, co-founder and CEO of Aelis Farma.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>La soci\u00e9t\u00e9 biopharmaceutique l\u00e8ve environ 25 millions [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":6393,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"pmpro_default_level":"","footnotes":""},"categories":[4],"tags":[],"class_list":["post-6391","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-operations","pmpro-has-access","entry","has-media"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aelis Farma a r\u00e9ussi son introduction en Bourse - Finascope<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/finascope.fr\/english\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aelis Farma a r\u00e9ussi son introduction en Bourse - Finascope\" \/>\n<meta property=\"og:description\" content=\"La soci\u00e9t\u00e9 biopharmaceutique l\u00e8ve environ 25 millions [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/finascope.fr\/english\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/\" \/>\n<meta property=\"og:site_name\" content=\"Finascope\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-17T06:22:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-18T12:14:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/finascope.fr\/wp-content\/uploads\/2022\/02\/Aelis-Farma-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"384\" \/>\n\t<meta property=\"og:image:height\" content=\"279\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Nicolas Raulot\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicolas Raulot\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/operations\\\/aelis-farma-a-reussi-son-introduction-en-bourse\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/operations\\\/aelis-farma-a-reussi-son-introduction-en-bourse\\\/\"},\"author\":{\"name\":\"Nicolas Raulot\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/#\\\/schema\\\/person\\\/7225790e8225e73e673f4460c957a3fe\"},\"headline\":\"Aelis Farma a r\u00e9ussi son introduction en Bourse\",\"datePublished\":\"2022-02-17T06:22:04+00:00\",\"dateModified\":\"2022-02-18T12:14:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/operations\\\/aelis-farma-a-reussi-son-introduction-en-bourse\\\/\"},\"wordCount\":528,\"publisher\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/operations\\\/aelis-farma-a-reussi-son-introduction-en-bourse\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/finascope.fr\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Aelis-Farma-1.png\",\"articleSection\":[\"Op\u00e9ration\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/operations\\\/aelis-farma-a-reussi-son-introduction-en-bourse\\\/\",\"url\":\"https:\\\/\\\/finascope.fr\\\/operations\\\/aelis-farma-a-reussi-son-introduction-en-bourse\\\/\",\"name\":\"Aelis Farma a r\u00e9ussi son introduction en Bourse - Finascope\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/operations\\\/aelis-farma-a-reussi-son-introduction-en-bourse\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/operations\\\/aelis-farma-a-reussi-son-introduction-en-bourse\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/finascope.fr\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Aelis-Farma-1.png\",\"datePublished\":\"2022-02-17T06:22:04+00:00\",\"dateModified\":\"2022-02-18T12:14:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/operations\\\/aelis-farma-a-reussi-son-introduction-en-bourse\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/finascope.fr\\\/operations\\\/aelis-farma-a-reussi-son-introduction-en-bourse\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/operations\\\/aelis-farma-a-reussi-son-introduction-en-bourse\\\/#primaryimage\",\"url\":\"https:\\\/\\\/finascope.fr\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Aelis-Farma-1.png\",\"contentUrl\":\"https:\\\/\\\/finascope.fr\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Aelis-Farma-1.png\",\"width\":384,\"height\":279},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/operations\\\/aelis-farma-a-reussi-son-introduction-en-bourse\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/finascope.fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aelis Farma a r\u00e9ussi son introduction en Bourse\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/#website\",\"url\":\"https:\\\/\\\/finascope.fr\\\/\",\"name\":\"Finascope\",\"description\":\"L&#039;info des march\u00e9s et des investissements \u00e0 Paris\",\"publisher\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/finascope.fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/#organization\",\"name\":\"Finascope\",\"url\":\"https:\\\/\\\/finascope.fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/finascope.fr\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/Logo-Finascope-500.jpeg\",\"contentUrl\":\"https:\\\/\\\/finascope.fr\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/Logo-Finascope-500.jpeg\",\"width\":500,\"height\":128,\"caption\":\"Finascope\"},\"image\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/#\\\/schema\\\/person\\\/7225790e8225e73e673f4460c957a3fe\",\"name\":\"Nicolas Raulot\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0b28951d3063a3c3439174ac769734c4f14a35a107e4e77fb6b5023ef041a0ab?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0b28951d3063a3c3439174ac769734c4f14a35a107e4e77fb6b5023ef041a0ab?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0b28951d3063a3c3439174ac769734c4f14a35a107e4e77fb6b5023ef041a0ab?s=96&d=mm&r=g\",\"caption\":\"Nicolas Raulot\"},\"url\":\"https:\\\/\\\/finascope.fr\\\/english\\\/author\\\/scofi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aelis Farma successfully completes IPO - Finascope","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/finascope.fr\/english\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/","og_locale":"en_GB","og_type":"article","og_title":"Aelis Farma a r\u00e9ussi son introduction en Bourse - Finascope","og_description":"La soci\u00e9t\u00e9 biopharmaceutique l\u00e8ve environ 25 millions [&hellip;]","og_url":"https:\/\/finascope.fr\/english\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/","og_site_name":"Finascope","article_published_time":"2022-02-17T06:22:04+00:00","article_modified_time":"2022-02-18T12:14:45+00:00","og_image":[{"width":384,"height":279,"url":"https:\/\/finascope.fr\/wp-content\/uploads\/2022\/02\/Aelis-Farma-1.png","type":"image\/png"}],"author":"Nicolas Raulot","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nicolas Raulot","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/finascope.fr\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/#article","isPartOf":{"@id":"https:\/\/finascope.fr\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/"},"author":{"name":"Nicolas Raulot","@id":"https:\/\/finascope.fr\/#\/schema\/person\/7225790e8225e73e673f4460c957a3fe"},"headline":"Aelis Farma a r\u00e9ussi son introduction en Bourse","datePublished":"2022-02-17T06:22:04+00:00","dateModified":"2022-02-18T12:14:45+00:00","mainEntityOfPage":{"@id":"https:\/\/finascope.fr\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/"},"wordCount":528,"publisher":{"@id":"https:\/\/finascope.fr\/#organization"},"image":{"@id":"https:\/\/finascope.fr\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/#primaryimage"},"thumbnailUrl":"https:\/\/finascope.fr\/wp-content\/uploads\/2022\/02\/Aelis-Farma-1.png","articleSection":["Op\u00e9ration"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/finascope.fr\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/","url":"https:\/\/finascope.fr\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/","name":"Aelis Farma successfully completes IPO - Finascope","isPartOf":{"@id":"https:\/\/finascope.fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/finascope.fr\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/#primaryimage"},"image":{"@id":"https:\/\/finascope.fr\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/#primaryimage"},"thumbnailUrl":"https:\/\/finascope.fr\/wp-content\/uploads\/2022\/02\/Aelis-Farma-1.png","datePublished":"2022-02-17T06:22:04+00:00","dateModified":"2022-02-18T12:14:45+00:00","breadcrumb":{"@id":"https:\/\/finascope.fr\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/finascope.fr\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/finascope.fr\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/#primaryimage","url":"https:\/\/finascope.fr\/wp-content\/uploads\/2022\/02\/Aelis-Farma-1.png","contentUrl":"https:\/\/finascope.fr\/wp-content\/uploads\/2022\/02\/Aelis-Farma-1.png","width":384,"height":279},{"@type":"BreadcrumbList","@id":"https:\/\/finascope.fr\/operations\/aelis-farma-a-reussi-son-introduction-en-bourse\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/finascope.fr\/"},{"@type":"ListItem","position":2,"name":"Aelis Farma a r\u00e9ussi son introduction en Bourse"}]},{"@type":"WebSite","@id":"https:\/\/finascope.fr\/#website","url":"https:\/\/finascope.fr\/","name":"Finascope","description":"Market and investment news from Paris","publisher":{"@id":"https:\/\/finascope.fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/finascope.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/finascope.fr\/#organization","name":"Finascope","url":"https:\/\/finascope.fr\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/finascope.fr\/#\/schema\/logo\/image\/","url":"https:\/\/finascope.fr\/wp-content\/uploads\/2021\/05\/Logo-Finascope-500.jpeg","contentUrl":"https:\/\/finascope.fr\/wp-content\/uploads\/2021\/05\/Logo-Finascope-500.jpeg","width":500,"height":128,"caption":"Finascope"},"image":{"@id":"https:\/\/finascope.fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/finascope.fr\/#\/schema\/person\/7225790e8225e73e673f4460c957a3fe","name":"Nicolas Raulot","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/0b28951d3063a3c3439174ac769734c4f14a35a107e4e77fb6b5023ef041a0ab?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0b28951d3063a3c3439174ac769734c4f14a35a107e4e77fb6b5023ef041a0ab?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0b28951d3063a3c3439174ac769734c4f14a35a107e4e77fb6b5023ef041a0ab?s=96&d=mm&r=g","caption":"Nicolas Raulot"},"url":"https:\/\/finascope.fr\/english\/author\/scofi\/"}]}},"_links":{"self":[{"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/posts\/6391","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/comments?post=6391"}],"version-history":[{"count":2,"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/posts\/6391\/revisions"}],"predecessor-version":[{"id":6414,"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/posts\/6391\/revisions\/6414"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/media\/6393"}],"wp:attachment":[{"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/media?parent=6391"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/categories?post=6391"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/tags?post=6391"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}